EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

A Risk Prediction Index for Amiodarone-Induced Thyrotoxicosis in Adults with Congenital Heart Disease

Marius N Stan, Erik P Hess, Rebecca S Bahn, Carole A Warnes, Naser M Ammash, Michael D Brennan, Prabin Thapa, Victor M Montori

Journal of Thyroid Research · 2012

DOI: 10.1155/2012/210529 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thyroid Research, 2012. Verfasst von Marius N Stan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NCRR NIH HHS, National Center for Research Resources.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amiodarone therapy in adults with congenital heart disease (CHD) is associated with a significant risk of amiodarone-induced thyrotoxicosis (AIT). We developed a risk index to identify those patients being considered for amiodarone treatment who are at high risk for AIT. We reviewed the health records of adults with CHD and assessed the association between potential clinical predictors and AIT. Significant predictors were included in multivariate analyses. The parameter estimates from multivariate analysis were subsequently used to develop a risk index. 169 adults met eligibility criteria and 23 developed AIT. The final model included age, cyanotic heart disease and BMI. The risk index developed identified 3 categories of risk. Their AIT likelihood ratios were: 0.37 for low risk (95% CI 0.15–0.92); 1.12 for medium risk (95% CI 0.65–1.91); and 3.47 for high risk (95% CI 1.7–7.11). The AIT predicted risk in our population was 5% for the low risk group, 15% for the medium risk group and 47% for the high risk group. Conclusions . We derived the first model to quantify the risk for developing AIT among adults with CHD. Before using it clinically to help selecting among alternative antiarrhythmic options, it needs validation in an independent population.

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA.

Förderung

  • NCRR NIH HHS
  • National Center for Research Resources

Zitieren

APA

Stan, M. N., Hess, E. P., Bahn, R. S., Warnes, C. A., Ammash, N. M., Brennan, M. D., Thapa, P., & Montori, V. M. (2012). A Risk Prediction Index for Amiodarone-Induced Thyrotoxicosis in Adults with Congenital Heart Disease. Journal of Thyroid Research. https://doi.org/10.1155/2012/210529

Vancouver

Stan MN, Hess EP, Bahn RS, Warnes CA, Ammash NM, Brennan MD, et al. A Risk Prediction Index for Amiodarone-Induced Thyrotoxicosis in Adults with Congenital Heart Disease. Journal of Thyroid Research. 2012. doi:10.1155/2012/210529

BibTeX
@article{Stan2012,
  author = {Stan, Marius N and Hess, Erik P and Bahn, Rebecca S and Warnes, Carole A and Ammash, Naser M and Brennan, Michael D and Thapa, Prabin and Montori, Victor M},
  title = {A Risk Prediction Index for Amiodarone-Induced Thyrotoxicosis in Adults with Congenital Heart Disease},
  journal = {Journal of Thyroid Research},
  year = {2012},
  doi = {10.1155/2012/210529}
}
Kostenlos starten →